Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-23-014843

EVP, CFO & Treasurer sold 11,205 shares at $3.03 ($33,942)

  • EVP, CFO & Treasurer acquired 95,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mason Michael · EVP, CFO & Treasurer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-02-28 Grant or award : show line 1 in the form +95,000 256,566 D
2023-03-01 Sale : show line 2 in the form −11,205 $3.03 $33,942 245,361 D
Open-market sales · 11,205 sh · avg $3.03 · $33,942
Loading xslF345X03/doc4.xml…